tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TSHA Stock Latest News

Taysha Gene Therapies price target raised to $9 from $8 at BofA
The FlyTaysha Gene Therapies price target raised to $9 from $8 at BofA
3d ago
TSHA
Taysha Gene Therapies Presents Promising TSHA-102 Data
PremiumCompany Announcements
Taysha Gene Therapies Presents Promising TSHA-102 Data
4d ago
8K
TSHA
Taysha Gene Therapies presents new supplemental data analysis from REVEAL study
PremiumThe Fly
Taysha Gene Therapies presents new supplemental data analysis from REVEAL study
4d ago
TSHA
Taysha Gene Therapies price target raised to $12 from $7 at Baird
PremiumThe Fly
Taysha Gene Therapies price target raised to $12 from $7 at Baird
10d ago
TSHA
Neurogene looks ‘deeply undervalued’ after Taysha news, says H.C. Wainwright
PremiumThe Fly
Neurogene looks ‘deeply undervalued’ after Taysha news, says H.C. Wainwright
11d ago
NGNE
TSHA
Taysha Gene Therapies price target raised to $12 from $7 at Baird
PremiumThe FlyTaysha Gene Therapies price target raised to $12 from $7 at Baird
11d ago
TSHA
Berkshire to acquire OxyChem, OpenAI reaches $500B valuation: Morning Buzz
Premium
The Fly
Berkshire to acquire OxyChem, OpenAI reaches $500B valuation: Morning Buzz
11d ago
BE
RH
Promising Prospects for Taysha Gene Therapies: Buy Rating Backed by Strategic Advancements and Regulatory Endorsements
Premium
Ratings
Promising Prospects for Taysha Gene Therapies: Buy Rating Backed by Strategic Advancements and Regulatory Endorsements
11d ago
TSHA
Needham ups Taysha target on ‘derisking’ TSHA-102 news
PremiumThe Fly
Needham ups Taysha target on ‘derisking’ TSHA-102 news
11d ago
TSHA
Taysha Gene Therapies price target raised to $10 from $8 at Needham
PremiumThe Fly
Taysha Gene Therapies price target raised to $10 from $8 at Needham
11d ago
TSHA
Positive Outlook for Taysha Gene Therapies: Buy Rating Affirmed with FDA Support and Breakthrough Designation
PremiumRatings
Positive Outlook for Taysha Gene Therapies: Buy Rating Affirmed with FDA Support and Breakthrough Designation
11d ago
TSHA
Taysha Gene Therapies Gains FDA Breakthrough Designation
PremiumCompany Announcements
Taysha Gene Therapies Gains FDA Breakthrough Designation
11d ago
8K
TSHA
Taysha Gene Therapies announces FDA BTD to TSHA-102
PremiumThe FlyTaysha Gene Therapies announces FDA BTD to TSHA-102
11d ago
TSHA
Taysha Gene Therapies announces inducement grant under Nasdaq listing rule
Premium
The Fly
Taysha Gene Therapies announces inducement grant under Nasdaq listing rule
1M ago
TSHA
Taysha Gene Therapies’ Earnings Call: Progress Amid Challenges
Premium
Company Announcements
Taysha Gene Therapies’ Earnings Call: Progress Amid Challenges
1M ago
TSHA
Positive Outlook for Taysha Gene Therapies: Buy Rating Reinforced by Strong Financial Position and Promising Clinical Progress
PremiumRatings
Positive Outlook for Taysha Gene Therapies: Buy Rating Reinforced by Strong Financial Position and Promising Clinical Progress
2M ago
TSHA
Taysha Gene Therapies price target raised to $14 from $11 at Canaccord
PremiumThe Fly
Taysha Gene Therapies price target raised to $14 from $11 at Canaccord
2M ago
TSHA
Taysha Gene Therapies Advances Rett Syndrome Trials
PremiumCompany Announcements
Taysha Gene Therapies Advances Rett Syndrome Trials
2M ago
TSHA
Taysha Gene Therapies price target raised to $10 from $9 at Chardan
PremiumThe Fly
Taysha Gene Therapies price target raised to $10 from $9 at Chardan
2M ago
TSHA
Taysha Gene Therapies: Positive Outlook with Pivotal Study and Strong Financial Health Justifies Buy Rating
PremiumRatingsTaysha Gene Therapies: Positive Outlook with Pivotal Study and Strong Financial Health Justifies Buy Rating
2M ago
TSHA
Taysha Gene Therapies reports Q2 EPS (9c), consensus (8c)
Premium
The Fly
Taysha Gene Therapies reports Q2 EPS (9c), consensus (8c)
2M ago
TSHA
TSHA Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
TSHA Earnings this Week: How Will it Perform?
2M ago
TSHA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >